Anastasiia A. Buianova

This study evaluates pharmacogenomic data in Russian children and newborns, highlighting the need for age-adjusted interpretation and developing a pediatric pharmacogenomics reporting model.

The paper creates a database of ACE variants linked to Alzheimer's disease, estimates their population frequency, and links them to reduced blood ACE levels.

This study demonstrates that GSK3β knockdown using siRNAs induces osteogenic differentiation of human adipose-derived MSCs through effective transfection with PEI.

The paper identifies monogenic variants in the Russian population associated with adverse drug reactions, highlighting their potential to improve personalized pharmacotherapy.

The paper analyzes pharmacogenomic variants in 6,102 Russian exomes, identifying key drug metabolism and toxicity-related variants and highlighting limitations of WES for non-coding variant imputation.

The paper identifies genetic variants in ANSD patients and shows differences in auditory tests between ANSD and SNHL groups, suggesting ASSR testing for better diagnosis.

This study identifies genetic variants associated with IgA nephropathy in pediatric patients through an exome-wide association analysis.